
34 min

Geoffrey Lynn, Vaccitech BioTalk with Rich Bendis
-
- Business
Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.
Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.
34 min